Blockchain Registration Transaction Record

Oncotelic Therapeutics Advances AI and Robotics Platform

Oncotelic Therapeutics reports progress on AI and robotics platform with 28 million scientific abstracts, nearing commercial deployment for pharmaceutical development.

This news matters because Oncotelic's integration of AI and robotics into pharmaceutical development could significantly accelerate the discovery and manufacturing of new treatments for high-unmet-need cancers and rare pediatric diseases. For investors and patients alike, this represents a potential shift toward more efficient, data-driven drug development, reducing time and costs while improving compliance. The use of 28 million scientific abstracts in their AI platform underscores the power of big data in healthcare, potentially leading to breakthroughs that benefit millions of patients worldwide.